Similar articles for PMID: 26621956

1

Cite

Share

Pneumonitis and pulmonary haemorrhage after acute myocardial infarction.

Parasuraman SK, Teo AI, Millar CG, Noman A. Parasuraman SK, et al. Clin Med (Lond). 2015 Dec;15(6):591-3. doi: 10.7861/clinmedicine.15-6-591. Clin Med (Lond). 2015. PMID: 26621956 Free PMC article.

Cite

Share

2

Cite

Share

Angiographic and electrocardiographic parameters of myocardial reperfusion in angioplasty of patients with ST elevation acute myocardial infarction loaded with ticagrelor or clopidogrel (MICAMI-TICLO trial).

Winter JL, Lindefjeld DS, Veas N, Guarda E, Valdebenito M, Méndez M, Pérez O, Zuanic K, Mestas M, Martínez A. Winter JL, et al. Cardiovasc Revasc Med. 2014 Jul-Aug;15(5):284-8. doi: 10.1016/j.carrev.2014.07.001. Epub 2014 Jul 12. Cardiovasc Revasc Med. 2014. PMID: 25178668 Clinical Trial.

Cite

Share

3

Cite

Share

Dual thienopyridine low-response to clopidogrel and prasugrel in a patient with STEMI, cardiogenic shock and early stent thrombosis is overcome by ticagrelor.

Orban M, Riegger J, Joner M, Tada T, Okrojek R, Hausleiter J, Kastrati A, Massberg S, Sibbing D. Orban M, et al. Platelets. 2012;23(5):395-8. doi: 10.3109/09537104.2012.691189. Epub 2012 Jun 6. Platelets. 2012. PMID: 22671583

Cite

Share

4

Cite

Share

Comparison of Prasugrel and Ticagrelor Antiplatelet Effects in Korean Patients Presenting With ST-Segment Elevation Myocardial Infarction.

Lee YS, Jin CD, Kim MH, Guo LZ, Cho YR, Park K, Park JS, Park TH, Kim YD. Lee YS, et al. Circ J. 2015;79(6):1248-54. doi: 10.1253/circj.CJ-15-0270. Epub 2015 May 11. Circ J. 2015. PMID: 25959558 Free article. Clinical Trial.

Cite

Share

5

Cite

Share

Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis.

Rafique AM, Nayyar P, Wang TY, Mehran R, Baber U, Berger PB, Tobis J, Currier J, Dave RH, Henry TD. Rafique AM, et al. JACC Cardiovasc Interv. 2016 May 23;9(10):1036-46. doi: 10.1016/j.jcin.2016.02.013. JACC Cardiovasc Interv. 2016. PMID: 27198684 Free article.

Cite

Share

6

Cite

Share

Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction.

Alexopoulos D, Xanthopoulou I, Gkizas V, Kassimis G, Theodoropoulos KC, Makris G, Koutsogiannis N, Damelou A, Tsigkas G, Davlouros P, Hahalis G. Alexopoulos D, et al. Circ Cardiovasc Interv. 2012 Dec;5(6):797-804. doi: 10.1161/CIRCINTERVENTIONS.112.972323. Epub 2012 Nov 20. Circ Cardiovasc Interv. 2012. PMID: 23169985 Clinical Trial.

Cite

Share

7

Cite

Share

A case of pulmonary hemorrhage due to drug-induced pneumonitis secondary to ticagrelor therapy.

Whitmore TJ, O'Shea JP, Starac D, Edwards MG, Waterer GW. Whitmore TJ, et al. Chest. 2014 Mar 1;145(3):639-641. doi: 10.1378/chest.13-1502. Chest. 2014. PMID: 24590025

Cite

Share

8

Cite

Share

Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention.

Velders MA, Abtan J, Angiolillo DJ, Ardissino D, Harrington RA, Hellkamp A, Himmelmann A, Husted S, Katus HA, Meier B, Schulte PJ, Storey RF, Wallentin L, Gabriel Steg P, James SK; PLATO Investigators. Velders MA, et al. Heart. 2016 Apr;102(8):617-25. doi: 10.1136/heartjnl-2015-308963. Epub 2016 Feb 4. Heart. 2016. PMID: 26848185 Clinical Trial.

Cite

Share

9

Cite

Share

Spontaneous omental bleeding in the setting of dual anti-platelet therapy with ticagrelor.

Cheng VE, Oppermen A, Natarajan D, Haikerwal D, Pereira J. Cheng VE, et al. Heart Lung Circ. 2014 Apr;23(4):e115-7. doi: 10.1016/j.hlc.2013.11.002. Epub 2013 Nov 26. Heart Lung Circ. 2014. PMID: 24480082

Cite

Share

10

Cite

Share

The use of ticagrelor in a patient at increased risk of stent thrombosis resistant to multiple thienopyridines.

Morgan KP, More RS, Chauhan A. Morgan KP, et al. Cardiology. 2011;119(2):88-9. doi: 10.1159/000329916. Epub 2011 Sep 6. Cardiology. 2011. PMID: 21912120

Cite

Share